Vanda Lennon

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
    Vanda A Lennon
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Exp Med 202:473-7. 2005
  2. ncbi request reprint A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
    Vanda A Lennon
    Department of Neurology, Mayo Clinic Rochester, Rochester, MN 55905, USA
    Lancet 364:2106-12. 2004
  3. pmc Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
    Vanda A Lennon
    Department of Immunology, Mayo Graduate and Medical Schools and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Invest 111:907-13. 2003
  4. ncbi request reprint Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG
    Shelley A Cross
    Department of Neurology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, MN 55905, USA
    Ann Neurol 54:38-50. 2003
  5. doi request reprint Aquaporin-4 autoantibodies in a paraneoplastic context
    Sean J Pittock
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arch Neurol 65:629-32. 2008
  6. ncbi request reprint Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome
    Sean J Pittock
    Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Ann Neurol 56:715-9. 2004
  7. ncbi request reprint Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
    Shanu F Roemer
    Department of Neurology, Mayo Clinic, College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Brain 130:1194-205. 2007
  8. doi request reprint Neuromyelitis optica and non organ-specific autoimmunity
    Sean J Pittock
    Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Arch Neurol 65:78-83. 2008
  9. ncbi request reprint Autoantibody profiles and neurological correlations of thymoma
    Steven Vernino
    Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Cancer Res 10:7270-5. 2004
  10. pmc Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments
    Andrew McKeon
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Arch Neurol 66:735-41. 2009

Research Grants

Detail Information

Publications56

  1. pmc IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
    Vanda A Lennon
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Exp Med 202:473-7. 2005
    ..NMO may represent the first example of a novel class of autoimmune channelopathy...
  2. ncbi request reprint A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
    Vanda A Lennon
    Department of Neurology, Mayo Clinic Rochester, Rochester, MN 55905, USA
    Lancet 364:2106-12. 2004
    ..We assessed the capacity of a putative marker for neuromyelitis optica (NMO-IgG) to distinguish neuromyelitis optica and related disorders from multiple sclerosis...
  3. pmc Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
    Vanda A Lennon
    Department of Immunology, Mayo Graduate and Medical Schools and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Invest 111:907-13. 2003
    ....
  4. ncbi request reprint Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG
    Shelley A Cross
    Department of Neurology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, MN 55905, USA
    Ann Neurol 54:38-50. 2003
    ..Positive serology obviates the need for vitreous biopsy and expedites the search for cancer...
  5. doi request reprint Aquaporin-4 autoantibodies in a paraneoplastic context
    Sean J Pittock
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arch Neurol 65:629-32. 2008
    ..Its antigen is the astrocytic water channel aquaporin-4; NMO-IgG has not been described in a cancer context...
  6. ncbi request reprint Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome
    Sean J Pittock
    Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Ann Neurol 56:715-9. 2004
    ..The autoantibody profiles observed in patients with paraneoplastic disorders imply the targeting of multiple onconeural antigens and predict the patient's neoplasm, but not a specific neurological syndrome...
  7. ncbi request reprint Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
    Shanu F Roemer
    Department of Neurology, Mayo Clinic, College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Brain 130:1194-205. 2007
    ..These findings strongly support a role for a complement activating AQP4-specific autoantibody as the initiator of the NMO lesion, and further distinguish NMO from MS...
  8. doi request reprint Neuromyelitis optica and non organ-specific autoimmunity
    Sean J Pittock
    Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Arch Neurol 65:78-83. 2008
    ..Neuromyelitis optica (NMO) is often associated with other clinical or serological markers of non-organ-specific autoimmunity...
  9. ncbi request reprint Autoantibody profiles and neurological correlations of thymoma
    Steven Vernino
    Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Cancer Res 10:7270-5. 2004
    ..Determine muscle and neuronal autoantibody frequencies in patients with thymoma, with and without paraneoplastic neurological accompaniments...
  10. pmc Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments
    Andrew McKeon
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Arch Neurol 66:735-41. 2009
    ..To describe the clinical utility of the nicotinic ganglionic acetylcholine receptor (alpha3-AChR) autoantibody as a marker of neurological autoimmunity and cancer...
  11. doi request reprint Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica
    Andrew McKeon
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Muscle Nerve 39:87-90. 2009
    ..0001. The coexistence of NMO and MG should be considered in atypical or refractory presentations of either disorder...
  12. pmc Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility
    Radhika Dhamija
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 6:988-92. 2008
    ..Here we report 24 Mayo Clinic patients in whom the profile of serum autoantibodies aided this diagnosis...
  13. ncbi request reprint Amphiphysin autoimmunity: paraneoplastic accompaniments
    Sean J Pittock
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Ann Neurol 58:96-107. 2005
    ..01). Overall, a minority of women (39%) and men (12%) had stiff-man phenomena. Only 10% of women (some with lung carcinoma) and 4% of men fulfilled diagnostic criteria for stiff-man syndrome...
  14. pmc Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease
    Michael D Geschwind
    Neuroimmunology Laboratory, Hilton 3 78F, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Arch Neurol 65:1341-6. 2008
    ..Rapidly progressive dementia has a variety of causes, including Creutzfeldt-Jakob disease (CJD) and neuronal voltage-gated potassium channel (VGKC) autoantibody-associated encephalopathy...
  15. doi request reprint Eliminating false-positive results in serum tests for neuromuscular autoimmunity
    Metha Apiwattanakul
    Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Muscle Nerve 41:702-4. 2010
    ..05% and 1.7% for AchR and VGKC autoantibodies, respectively. Specificity assurance in radioimmunoprecipitation assays requires subtraction of values for 125I-ligand binding...
  16. ncbi request reprint Frequency of seronegativity in adult-acquired generalized myasthenia gravis
    Koon Ho Chan
    Department of Laboratory Medicine and Pathology, Mayo Clinic, College of Medicine, 200 First Street S W, Rochester, Minnesota 55905, USA
    Muscle Nerve 36:651-8. 2007
    ..Classification as seronegative MG should be reserved for nonimmunosuppressed patients with generalized MG who lack muscle AChR binding, AChR modulating, or MuSK antibodies at presentation and at follow-up of at least 12 months...
  17. pmc Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease
    Setty M Magaña
    Department of Neurology, Mayo Clinic College of Medicine, 200 First Ave SW, Rochester, MN 55902, USA
    Arch Neurol 66:964-6. 2009
    ..To our knowledge, this study is the first to compare NMO IgG serostatus among patients with fulminant central nervous system inflammatory demyelinating disease (CNS IDD)...
  18. ncbi request reprint Metastatic chondroblastoma with elevated creatine kinase and paraneoplastic neurologic autoimmunity
    Divya Devi Joshi
    Division of Pediatric Hematology Oncology, Mayo Clinic Rochester, Minnesota 55905, USA
    J Pediatr Hematol Oncol 25:900-4. 2003
    ..The association of metastatic chondroblastoma, elevated CK, and an evolving profile of paraneoplastic autoantibodies reveals a previously unrecognized immunobiologic dimension of chondroblastoma...
  19. doi request reprint Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images
    Andrew McKeon
    Department of Neurology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Arch Neurol 66:268-71. 2009
    ..To describe reversible extralimbic paraneoplastic encephalopathies with large, lobar lesions on magnetic resonance imaging (MRI)...
  20. ncbi request reprint The spectrum of autoimmune autonomic neuropathies
    Caroline M Klein
    Department of Neurology, Medical University of South Carolina, Charleston, SC, USA
    Ann Neurol 53:752-8. 2003
    ....
  21. ncbi request reprint The spectrum of neuromyelitis optica
    Dean M Wingerchuk
    Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ 85259, USA
    Lancet Neurol 6:805-15. 2007
    ..The knowledge gained from further assessment of the exact role of NMO-IgG in the pathogenesis of neuromyelitis optica will provide a foundation for rational therapeutic trials for this rapidly disabling disease...
  22. ncbi request reprint Whole-body tremulousness: isolated generalized polymyoclonus
    Andrew McKeon
    Department of Neurology, Gonda 8 South, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA
    Arch Neurol 64:1318-22. 2007
    ..Acquired generalized repetitive myoclonus may be mistaken for tremor. Distinguishing myoclonus has etiologic and therapeutic implications...
  23. doi request reprint Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G
    B Mark Keegan
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Ann Neurol 63:531-4. 2008
    ..Collapsin response-mediator protein-5 autoimmune myelopathy and occult neoplasia are important considerations in patients with insidiously progressive myelopathy, especially with known cancer risk...
  24. doi request reprint Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri)
    Sean J Pittock
    Mayo Medical School College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Arch Neurol 67:1109-15. 2010
    ..However, the neurologic spectrum of ANNA-2 autoimmunity is broader, includes a syndrome of jaw dystonia and laryngospasm, and can be accompanied by lung carcinoma...
  25. pmc Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
    Shannon R Hinson
    Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Exp Med 205:2473-81. 2008
    ..Thus, binding of NMO-IgG to astrocytic AQP4 initiates several potentially neuropathogenic mechanisms: complement activation, AQP4 and EAAT2 down-regulation, and disruption of glutamate homeostasis...
  26. doi request reprint Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays
    Andrew McKeon
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arch Neurol 66:1134-8. 2009
    ....
  27. pmc Peripherin-IgG association with neurologic and endocrine autoimmunity
    Jayne L Chamberlain
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Autoimmun 34:469-77. 2010
    ..It remains to be determined whether or not peripherin-IgG is predictive for development of small fiber neuropathy (autonomic or somatic)...
  28. ncbi request reprint NMO-IgG: a specific biomarker for neuromyelitis optica
    Brian G Weinshenker
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Dis Markers 22:197-206. 2006
    ....
  29. ncbi request reprint Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction
    Sean J Pittock
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 81:1207-14. 2006
    ..To describe novel neurological manifestations associated with glutamic acid decarboxylase (GAD65) autoimmunity...
  30. doi request reprint Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells
    Shannon R Hinson
    Department of Laboratory Medicine and Pathology, Hilton 3 78D, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arch Neurol 66:1164-7. 2009
    ..The NMO-IgG binds in vitro to the extracellular domain of AQP4, activates complement, and causes astrocyte lesioning...
  31. ncbi request reprint Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability
    Steven Vernino
    Department of Neurology, Mayo Clinic and Mayo Foundation, 200 First Street S W, Rochester, Minnesota 55905, USA
    Muscle Nerve 26:702-7. 2002
    ..We conclude that acquired neuromuscular hyperexcitability consists of a continuum of clinical disorders with a common autoimmune pathogenesis...
  32. ncbi request reprint Neuronal ganglionic acetylcholine receptor autoimmunity
    Steven Vernino
    Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Ann N Y Acad Sci 998:211-4. 2003
    ..These patients often have a high antibody value (>0.2 nmol/L). Lower values (0.05-0.20 nmol/L) are found in approximately 10% of patients with limited AAN...
  33. ncbi request reprint ACh receptor protein drives primary and memory autoantibody responses in chimeric human-SCID mice
    Hiroaki Yoshikawa
    Department of Immunology, Mayo Graduate School and Medical School, Mayo Clinic, Rochester, MN 55905, USA
    Clin Immunol 104:128-37. 2002
    ..In healthy subjects, AChR-specific lymphocytes are infrequent and exhibit naive response characteristics, including apparent affinity maturation of Ig specificity...
  34. pmc Passive transfer of autoimmune autonomic neuropathy to mice
    Steven Vernino
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Neurosci 24:7037-42. 2004
    ..The antibody effect is potentially reversible, justifying early use of immunomodulatory therapy directed at lowering IgG levels and abrogating IgG production in patients with AAN...
  35. ncbi request reprint Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
    Brian G Weinshenker
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Ann Neurol 59:566-9. 2006
    ..We investigated whether neuromyelitis optica (NMO) IgG seropositivity at the initial presentation of longitudinally extensive transverse myelitis (LETM) predicts relapse of myelitis or development of optic neuritis...
  36. ncbi request reprint Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma
    Steven Vernino
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Ann Neurol 51:625-30. 2002
    ..Four patients improved with chemotherapy, and 2 improved with intravenous methylprednisolone...
  37. ncbi request reprint Muscle and neuronal autoantibody markers of thymoma: neurological correlations
    Steven Vernino
    Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Ann N Y Acad Sci 998:359-61. 2003
  38. ncbi request reprint Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression
    Sean J Pittock
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905 0001, USA
    Arch Neurol 63:964-8. 2006
    ..Although it is conventionally believed that the brain is spared, brain imaging abnormalities are not uncommon in patients with NMO...
  39. ncbi request reprint Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments
    Sean J Pittock
    Department of Neurology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, MN 55905, USA
    Ann Neurol 53:580-7. 2003
    ....
  40. ncbi request reprint Paraneoplastic dysmotility: loss of interstitial cells of Cajal
    Darrell S Pardi
    Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:1828-33. 2002
    ..The histopathology of this case suggests that interstitial cells of Cajal may be a target in the pathogenesis of paraneoplastic motility disorders...
  41. ncbi request reprint Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma
    Steven Vernino
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Neurology 59:929-32. 2002
    ..Retrospective testing of stored serum from 172 patients with thymoma revealed ANNA-1 in 3%. This report extends the oncologic implications of ANNA-1 seropositivity...
  42. pmc Neural autoantibody profile of primary achalasia
    Robert E Kraichely
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Dig Dis Sci 55:307-11. 2010
    ..5% in control subjects), in the absence of diabetes or companion antibodies predictive of type 1 diabetes. This profile of autoantibodies suggests an autoimmune basis for a subset of primary achalasia...
  43. ncbi request reprint Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine
    Shabana F Pasha
    Department of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA
    Gastroenterology 131:1592-6. 2006
    ..This disorder is considered rare, but is underrecognized as a cause for GI dysmotilities of varying anatomic extent, severity, and duration. We describe the diagnosis and management of an instructive case...
  44. ncbi request reprint Experimental autoimmune autonomic neuropathy
    Steven Vernino
    Department of Neurology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Neurophysiol 90:2053-9. 2003
    ..These findings define the autonomic physiology and histopathology of this novel animal model and support the concept that AAN in humans is a disorder of ganglionic cholinergic synaptic transmission caused by ganglionic nAChR antibodies...
  45. ncbi request reprint Brain abnormalities in neuromyelitis optica
    Sean J Pittock
    Department of Neurology, Laboratory Medicine and Pathology, Radiology, and Immunology, Mayo Clinic College of Medicine, Rochester, Minn, USA
    Arch Neurol 63:390-6. 2006
    ..We have, however, frequently encountered patients with a well-established diagnosis of NMO in whom either asymptomatic or symptomatic brain lesions develop suggesting that the diagnostic criteria for NMO should be revised...
  46. ncbi request reprint Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody
    Paola Sandroni
    Department of Neurology, Mayo Foundation, Guggenheim 811, 200 First Street SW, Rochester, MN 55905, USA
    Arch Neurol 61:44-8. 2004
    ....
  47. ncbi request reprint Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody
    Ali Samii
    Department of Neurology, University of Washington School of Medicine, Seattle, Washington, USA
    Mov Disord 18:1556-8. 2003
    ..We report on details of a movement disorder that followed anti-B-cell therapy in a patient with lymphoma, and was accompanied by CRMP-5 IgG...
  48. ncbi request reprint Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
    Haidong Dong
    Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA
    Nat Med 8:793-800. 2002
    ..These findings have implications for the design of T cell-based cancer immunotherapy...
  49. ncbi request reprint Postural orthostatic tachycardia syndrome: the Mayo clinic experience
    Mark J Thieben
    Autonomic Disorders Center, Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 82:308-13. 2007
    ..To evaluate the prevalence and pathogenetic mechanisms of postural orthostatic tachycardia syndrome (POTS)...
  50. doi request reprint Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review
    Andrew McKeon
    Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Arch Neurol 67:322-9. 2010
    ..To evaluate the cancer detection rate of whole-body positron emission tomography-computed tomography (PET-CT) in a paraneoplastic neurologic context...
  51. doi request reprint An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study
    Daniel H LaChance
    Department of Neurology, Mayo Clinic, Rochester, MN, USA Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Lancet Neurol 9:55-66. 2010
    ..We aimed to describe the pathogenic and immunological characteristics of this illness...
  52. doi request reprint Intractable vomiting as the initial presentation of neuromyelitis optica
    Metha Apiwattanakul
    Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Ann Neurol 68:757-61. 2010
    ..Our clinical, pathologic and neuroimaging observations suggest the aquaporin-4-rich area postrema may be a first point of attack in neuromyelitis optica...
  53. pmc Autoimmune dementia: clinical course and predictors of immunotherapy response
    Eoin P Flanagan
    Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 85:881-97. 2010
    ..To define the diagnostic characteristics and predictors of treatment response in patients with suspected autoimmune dementia...
  54. ncbi request reprint OSMS is NMO, but not MS: proven clinically and pathologically
    Brian G Weinshenker
    Lancet Neurol 5:110-1. 2006
  55. ncbi request reprint Autoimmune autonomic neuropathy. An immunopharmacological disease
    Vanda A Lennon
    Clin Auton Res 12:225-7. 2002
  56. ncbi request reprint Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
    Colin F Fletcher
    Ann Neurol 53:5-7. 2003

Research Grants5

  1. Spectrum of Autoimmune Gastrointestinal Dysmotility
    Vanda Lennon; Fiscal Year: 2009
    ..l.dysmotilities, and justify early consideration of immunomodulatory therapies. The proposed research also has high clinical relevance to cancer immunity. ..